Table 3.
## | miRNA | p | p.adj |
---|---|---|---|
1 | miR.324.5p | 0.967 | 0.817 |
2 | miR.9 | 0.383 | 0.779 |
3 | miR.21 | 0.090 | 0.020 |
4 | miR.31 | 0.343 | 0.231 |
5 | miR.33b | 0.011 | 0.017 |
6 | miR.96 | 0.631 | 0.342 |
7 | miR.105 | 0.677 | 0.142 |
8 | miR.146a.5p | 0.358 | 0.340 |
9 | miR.182.5p | 0.840 | 0.687 |
10 | miR.196b | 0.385 | 0.587 |
11 | miR.199b.5p | 0.640 | 0.562 |
12 | miR.200a | 0.799 | 0.396 |
13 | miR.200b | 1.000 | 0.959 |
14 | miR.205 | 0.664 | 0.793 |
15 | miR.212 | 0.153 | 0.033 |
16 | miR.221 | 0.932 | 0.386 |
17 | miR.345 | 0.113 | 0.081 |
18 | miR.429 | 1.000 | 0.601 |
19 | miR.767 | 0.236 | 0.476 |
20 | miR.944 | 0.053 | 0.404 |
21 | miR.1269a | 0.059 | 0.496 |
22 | miR.1293 | 0.102 | 0.230 |
23 | miR.1910 | 0.261 | 0.154 |
24 | miR.3662 | 0.862 | 0.539 |
The univariate models included adjustments for clinical factors of age, gender, smoking status (current, former, never), smoking pack-years and quit-years, and underlying lung disease. Underlying lung disease: For all models, underlying lung disease was treated as trichotomous (COPD /fibrosis//inflammation NOS, asthma) versus sarcoidosis/bronchiectasis) versus none/other. Housekeeper transcript miR423-5p is not listed.